64 related articles for article (PubMed ID: 12089864)
1. Medullary thyroid carcinomas in cell culture--models for future therapies.
Pfragner R; Wirnsberger GH; Ingolic E; Niederle B
Wien Klin Wochenschr; 2002 Apr; 114(7):279-83. PubMed ID: 12089864
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of continuous cell line MTC-SK derived from a human medullary thyroid carcinoma.
Pfragner R; Höfler H; Behmel A; Ingolic E; Walser V
Cancer Res; 1990 Jul; 50(13):4160-6. PubMed ID: 1972348
[TBL] [Abstract][Full Text] [Related]
3. Activity of novel plant extracts against medullary thyroid carcinoma cells.
Rinner B; Siegl V; Pürstner P; Efferth T; Brem B; Greger H; Pfragner R
Anticancer Res; 2004; 24(2A):495-500. PubMed ID: 15152949
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative and pro-apoptotic effects of Uncaria tomentosa in human medullary thyroid carcinoma cells.
Rinner B; Li ZX; Haas H; Siegl V; Sturm S; Stuppner H; Pfragner R
Anticancer Res; 2009 Nov; 29(11):4519-28. PubMed ID: 20032400
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of oncogenic RET and loss of p18 on medullary thyroid carcinoma development.
van Veelen W; van Gasteren CJ; Acton DS; Franklin DS; Berger R; Lips CJ; Höppener JW
Cancer Res; 2008 Mar; 68(5):1329-37. PubMed ID: 18316595
[TBL] [Abstract][Full Text] [Related]
6. The effect of calcitriol and its analogues on proliferation and hormone expression in cultured cells of thyroid medullary carcinomas.
Zabel M; Flig K; Gebarowska E; Surdyk-Zasada J
Folia Morphol (Warsz); 2003 Nov; 62(4):463-5. PubMed ID: 14655142
[TBL] [Abstract][Full Text] [Related]
7. Suberoyl bis-hydroxamic acid activates Notch-1 signaling and induces apoptosis in medullary thyroid carcinoma cells.
Ning L; Greenblatt DY; Kunnimalaiyaan M; Chen H
Oncologist; 2008 Feb; 13(2):98-104. PubMed ID: 18305053
[TBL] [Abstract][Full Text] [Related]
8. Anticancer activity of novel extracts from Cautleya gracilis (Smith) Dandy: apoptosis in human medullary thyroid carcinoma cells.
Li Z; Sturm S; Svejda B; Höger H; Schraml E; Ingolic E; Siegl V; Stuppner H; Pfragner R
Anticancer Res; 2008; 28(5A):2705-13. PubMed ID: 19035299
[TBL] [Abstract][Full Text] [Related]
9. The effect of extracellular substance components on the proliferation and expression of hormones in cultured cells of medullary thyroid carcinomas.
Zabel M; Gebarowska E; Surdyk-Zasada J; Lesisz I; Kasprzak A; Seidel J
Folia Morphol (Warsz); 2004 Feb; 63(1):63-6. PubMed ID: 15039902
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of thyroid medullary carcinoma TT cell line.
Zabel M; Grzeszkowiak J
Histol Histopathol; 1997 Jan; 12(1):283-9. PubMed ID: 9046062
[TBL] [Abstract][Full Text] [Related]
11. Effect of Bcl-2 antisense oligonucleotide on drug-sensitivity in association with apoptosis in undifferentiated thyroid carcinoma.
Kim R; Tanabe K; Uchida Y; Emi M; Toge T
Int J Mol Med; 2003 Jun; 11(6):799-804. PubMed ID: 12736725
[TBL] [Abstract][Full Text] [Related]
12. Medullary thyroid carcinoma: autologous tumor cell lines for dendritic cell vaccination.
Pfragner R; Skofitsch G; Höger H; Jech M; Rinner B; Siegl V; Niederle B; Gnant M; Friedl J; Stift A
Anticancer Res; 2005; 25(6B):4225-30. PubMed ID: 16309220
[TBL] [Abstract][Full Text] [Related]
13. RET tyrosine kinase and medullary thyroid cells are unaffected by clinical doses of STI571.
Skinner MA; Safford SD; Freemerman AJ
Anticancer Res; 2003; 23(5A):3601-6. PubMed ID: 14666655
[TBL] [Abstract][Full Text] [Related]
14. The RET kinase inhibitor NVP-AST487 blocks growth and calcitonin gene expression through distinct mechanisms in medullary thyroid cancer cells.
Akeno-Stuart N; Croyle M; Knauf JA; Malaguarnera R; Vitagliano D; Santoro M; Stephan C; Grosios K; Wartmann M; Cozens R; Caravatti G; Fabbro D; Lane HA; Fagin JA
Cancer Res; 2007 Jul; 67(14):6956-64. PubMed ID: 17638907
[TBL] [Abstract][Full Text] [Related]
15. Human oral cancers have altered expression of Bcl-2 family members and increased expression of the anti-apoptotic splice variant of Mcl-1.
Mallick S; Patil R; Gyanchandani R; Pawar S; Palve V; Kannan S; Pathak KA; Choudhary M; Teni TR
J Pathol; 2009 Feb; 217(3):398-407. PubMed ID: 19009587
[TBL] [Abstract][Full Text] [Related]
16. Targeting of cell survival genes using small interfering RNAs (siRNAs) enhances radiosensitivity of Grade II chondrosarcoma cells.
Kim DW; Seo SW; Cho SK; Chang SS; Lee HW; Lee SE; Block JA; Hei TK; Lee FY
J Orthop Res; 2007 Jun; 25(6):820-8. PubMed ID: 17343283
[TBL] [Abstract][Full Text] [Related]
17. Novel treatment of medullary thyroid cancer.
Sugawara M; Geffner DL; Martinez D; Hershman JM
Curr Opin Endocrinol Diabetes Obes; 2009 Oct; 16(5):367-72. PubMed ID: 19633548
[TBL] [Abstract][Full Text] [Related]
18. Ghrelin in human medullary thyroid carcinomas.
Morpurgo PS; Cappiello V; Verga U; Vicentini L; Vaghi I; Lauri E; Nebuloni M; Beck-Peccoz P; Spada A
Clin Endocrinol (Oxf); 2005 Oct; 63(4):437-41. PubMed ID: 16181236
[TBL] [Abstract][Full Text] [Related]
19. Medullary thyroid carcinoma: including MEN 2A and MEN 2B syndromes.
Quayle FJ; Moley JF
J Surg Oncol; 2005 Mar; 89(3):122-9. PubMed ID: 15719378
[TBL] [Abstract][Full Text] [Related]
20. Novel histone deacetylase inhibitors in the treatment of thyroid cancer.
Mitsiades CS; Poulaki V; McMullan C; Negri J; Fanourakis G; Goudopoulou A; Richon VM; Marks PA; Mitsiades N
Clin Cancer Res; 2005 May; 11(10):3958-65. PubMed ID: 15897598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
